RxDoctor Payments DataLook up a doctor →

Csaba Kovesdy

Nephrology · Salem, VANPI 1477553022

Payments from drug & device makers

$1,516,309in general payments, 2019–2025

Across 714 payments — averaging $2123.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer$429K
  • Astrazeneca UK Limited$354K
  • Akebia Therapeutics Inc$236K
  • GSK$184K
  • AstraZeneca$138K
  • Gilead$46K
  • plus $129K from 13 others
$1,128in research payments, 2019–2025

Across 10 payments — averaging $112.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Gilead$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,516,309 in reported general payments places this provider in the 95th percentile of 298 nephrology providers in Virginia.

See all nephrology providers in Virginia

Other nephrology in Salem

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →